bioRxivPhysiology
Protective role of neuronal and lymphoid cannabinoid CB2 receptors in neuropathic pain
D. Cabanero, A. Ramirez-Lopez, E. Drews, A. Schmöle, D. M. Otte, A. Wawrzczak-Bargiela, H. Huerga Encabo, S. Kummer, R. Przewlocki, A. Zimmer, R. Maldonado
Abstract
Cannabinoid CB2 receptor (CB2r) agonists are potential painkillers void of psychotropic effects. Peripheral immune cells, neurons and glia express CB2r, however the involvement of CB2r from these cells in neuropathic pain remains unresolved. We explored spontaneous neuropathic pain through on-demand self-administration of the selective CB2r agonist JWH133 in wild-type and knockout mice lacking CB2r in neurons, monocytes or constitutively. Operant self-administration reflected drug-taking to alleviate spontaneous pain, nociceptive and affective manifestations. While constitutive deletion of CB2r disrupted JWH133-taking behavior, this behavior was not modified in monocyte-specific CB2r knockouts and was increased in mice defective in neuronal CB2r knockouts suggestive of increased spontaneous pain. Interestingly, CB2r-positive lymphocytes infiltrated the injured nerve and possible CB2r transfer from immune cells to neurons was found. Lymphocyte CB2r depletion also exacerbated JWH133 self-administration and inhibited antinociception. This work identifies a simultaneous activity of neuronal and lymphoid CB2r that protects against spontaneous and evoked neuropathic pain.
- organism: mouse
- assay: behavioral assay
- research focus: host-pathogen & immune response
- research focus: synaptic & neural circuits
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Hippocampal CA3 Nex/Neurod6+ neuron-specific TNFR2 alleviates chronic neuropathic pain by sex-dependently engaging opioid and endocannabinoid pathways
Sreejita Arnab, Payam A. Fathi, … John R. Bethea·bioRxiv·Nov 24, 2025
- Peripheral sensory neuron CB2 cannabinoid receptors are necessary for both CB2-mediated antinociceptive efficacy and sparing of morphine tolerance in a mouse model of neuropathic pain
Lawrence M. Carey, Zhili Xu, … Andrea G. Hohmann·bioRxiv·May 16, 2022
- Cannabinoid CB2 receptors in primary sensory neurons are implicated in CB2 agonist-mediated suppression of paclitaxel-induced neuropathic nociception and sexually-dimorphic sparing of morphine tolerance
Kelsey G. Guenther, Xiaoyan Lin, … Andrea G. Hohmann·Biomedicine & PharmacotherapyPeer-reviewed·Jun 7, 2024
- Assessments of Evoked and Spontaneous Pain Following Administration of Gabapentin and the Cannabinoid CB2 agonist LY2828360 in a Rat Model of Spared Nerve Injury
Kelsey G. Guenther, Jonathon D. Crystal, Andrea G. Hohmann·Cannabis and Cannabinoid ResearchPeer-reviewed·Apr 4, 2026
- Nociceptor-restricted cannabinoid receptor 1 contributes to chronic but not acute analgesia
Amber L. Milligan, Audrey R Green, … Michael D. Burton·bioRxiv·Aug 21, 2026
- A peripherally restricted cannabinoid 1 receptor agonist provides analgesic benefit from neuropathic pain and a lack of addiction-related behavior
Amie L. Severino, Lindsay M. Lueptow, … Catherine M. Cahill·bioRxiv·Apr 15, 2026